{"entity":{"id":"nct03906331","kind":"trial","name":"Selpercatinib RET expanded access","aka":["Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation"],"tldr":"This expanded-access record concerns selpercatinib for cancers with activating RET changes. The registry now marks the program approved for marketing; this does not mean the former access program is recruiting.","summary":"This expanded-access record concerns selpercatinib for cancers with activating RET changes. The registry now marks the program approved for marketing; this does not mean the former access program is recruiting.\n\nExpanded access study registered as NCT03906331, sponsored by Eli Lilly and Company. No drug-development phase applies in the structured registry record. Registry status checked October 10, 2026: approved for marketing. UCSF lists this study as closed to local enrollment; local availability and overall registry status are separate. See the registry for full eligibility and current sites.","asOf":"2026-10-10","links":[{"label":"ClinicalTrials.gov NCT03906331","url":"https://clinicaltrials.gov/study/NCT03906331"},{"label":"UCSF study listing and local availability","url":"https://clinicaltrials.ucsf.edu/trial/NCT03906331"}],"tags":["ucsf-breast-coverage","expanded-access"],"related":[],"cancers":["breast-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["selpercatinib"],"companies":[],"institutions":["ucsf"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT03906331","phase":"not-applicable","setting":"Cancers with activating RET alterations","sponsor":"Eli Lilly and Company","participation":[{"nct":"NCT03906331","source":"https://clinicaltrials.gov/study/NCT03906331","fetchedAt":"2026-10-10T20:54:23.115792Z","studySha256":"4f69eb111522f555f8804537fce4a2ba0e87bf1e41b8ee4bd23fc891bfc2fd01","overallStatus":"APPROVED_FOR_MARKETING","lastUpdatePosted":"2025-01-17","leadSponsor":"Eli Lilly and Company","collaboratorCount":0,"minimumAge":"18 Years","sex":"ALL","hasEligibility":true,"siteCount":64,"recruitingSiteCount":0,"countries":["Australia","France","Germany","Hong Kong","Israel","Italy","Japan","New Zealand","Poland","Singapore","Spain","Switzerland","United States"]}],"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct03906331/","neighbours":{"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"}],"drug":[{"id":"selpercatinib","kind":"drug","name":"Selpercatinib","route":"/drugs/selpercatinib/"}],"institution":[{"id":"ucsf","kind":"institution","name":"UCSF Helen Diller Family Comprehensive Cancer Center","route":"/institutions/ucsf/"}]}}